Christopher Bloomstran Semper Augustus Investments Group
Christopher Bloomstran is the president of Semper Augustus Investments Group, a value-oriented firm with a multi-decade focus on capital preservation and thoughtful security selection. He is known for detailed annual letters that discuss portfolio construction, accounting quality, and long-term ownership of businesses such as Berkshire Hathaway. Bloomstran’s work is popular among investors who prefer process transparency over short-term trading narratives.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$2.01M |
| 2 |
DST
DST Systems Inc.
DST
|
+$252K |
| 3 |
Microsoft
MSFT
|
+$23.5K |
| 4 |
GG
Goldcorp Inc
GG
|
+$17.7K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$14.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$398K |
| 2 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
+$34K |
| 3 |
Johnson & Johnson
JNJ
|
+$12.7K |
| 4 |
Equinor
EQNR
|
+$7.13K |
| 5 |
Newmont
NEM
|
+$7.01K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 51.97% |
| 2 | Energy | 15.77% |
| 3 | Materials | 7.85% |
| 4 | Healthcare | 7.62% |
| 5 | Technology | 7.02% |
Similar funds
Christopher Bloomstran's Q1 2015 Portfolio in Review
As of Q1 2015, Christopher Bloomstran held 32 positions worth $154M, down 1.7% from $157M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Christopher Bloomstran's Q1 2015 filing shows 2 new, 4 increased, 6 reduced and 1 closed positions. Its largest new stake was American Express: 24,143 shares worth $1.89M. The largest sale was Merck, an estimated $398K.
By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 51% a quarter earlier, followed by Energy and Materials.
- Christopher Bloomstran's largest Q1 2015 buy was American Express: 24,143 shares worth $1.89M.
- Christopher Bloomstran added most to Microsoft in Q1 2015, an estimated $23.5K increase.
- Christopher Bloomstran's biggest Q1 2015 reduction was Merck, cutting an estimated $398K.
- Christopher Bloomstran fully exited Ampio Pharmaceuticals Inc. in Q1 2015, selling an estimated $34K.
- Christopher Bloomstran's ten largest holdings make up 74% of its $154M portfolio in Q1 2015.
- Christopher Bloomstran opened 2 new positions and closed 1 in Q1 2015.
- Christopher Bloomstran's portfolio value fell 1.7% quarter-over-quarter to $154M.
Based on Semper Augustus Investments Group's 13F filing for Q1 2015, filed 14 May 2015.